VCTX211

Serial Number 97459047
606

Registration Progress

Application Filed
Jun 15, 2022
Under Examination
Nov 28, 2023
Approved for Publication
Oct 3, 2023
Published for Opposition
Oct 3, 2023
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: VCTX211
Previous Owner: CRISPR Therapeutics AG
Classes: 042

Trademark Image

VCTX211

Basic Information

Serial Number
97459047
Filing Date
June 15, 2022
Published for Opposition
October 3, 2023
Abandonment Date
July 1, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 1, 2024
Classes
042

Rights Holder

CRISPR Therapeutics AG

99
Address
Baarerstrasse 14
ZUG V8 SWITZERLAND 6300
CH

Ownership History

CRISPR Therapeutics AG

Original Applicant
99
ZUG V8 SWITZERLAND CH

CRISPR Therapeutics AG

Owner at Publication
99
ZUG V8 SWITZERLAND CH

Legal Representation

Attorney
Tiffany D. Gehrke

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

18 events
Date Code Type Description Documents
Jul 12, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jul 1, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 28, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 3, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 3, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 13, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 25, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 27, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 27, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 27, 2023 ALIE A ASSIGNED TO LIE Loading...
Jul 3, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 20, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 10, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 10, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 10, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 7, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 28, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 18, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development

Additional Information

Pseudo Mark
VCTX TWO ONE ONE; VCTX TWO HUNDRED ELEVEN
Pseudo Mark
VCTX 211

Classification

International Classes
042